Skip to main content
. 2011 Mar 18;117(19):5250–5256. doi: 10.1182/blood-2011-01-329706

Table 1.

Characteristics of 21 transplant recipients

Recipient age, y (range) 36 (13-56)
Donor age, y (range) 36 (16-58)
Sex, n (%)
    Male 11 (52)
    Female 10 (48)
Disease distribution
    CML 17 (81)
    AML/MDS 3 (14)
    MM 1 (5)
Stem cell source
    BM 15 (71)
    PBSC 6 (29)
Acute GVHD grade II-IV 6 (29)
History of cGVHD
    None 3 (14)
    Limited 13 (62)
    Extensive 5 (24)*
IST for cGVHD
    > 3 years 6 (29)
    At study 1 (5)
Follow-up period, years, median (range) 12 (10-15)

ALL indicates acute lymphoblastic leukemia; AML, acute myelogenous leukemia; cGVHD, chronic graft-versus-host disease; CML, chronic myelogenous leukemia; GVHD, graft-versus-host disease; IST, immunosuppressive therapy; MDS, myelodysplastic syndrome; and MM, multiple myeloma.

*

One recipient with active cGVHD at the time of study.